170964-45-1

Upstream product

• 170964-44-0 (R)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid (R)-13-methyl-1-[(R)-2-sulfo-1-((R)-3,3,3-trifluoro-2-methoxy-2-phenyl-propionylamino)-ethyl]-tetradecyl ester 
• 170242-21-4 (2R,3R)-3-Hydroxy-2-(13'-methyltetradecanoylamino)-15-methylhexadecanesulfonic acid 
• 171038-92-9 (2R,3R)-2-amino-3-hydroxy-15-methyl-hexadecan-1-sulfonic acid 
• 169217-35-0 (2R,3R,3'R)-3-hydroxy-2-(3'-hydroxy-15'-methylhexadecanoylamino)-15-methyl-hexadecan-1-sulfonic acid 
• 39637-99-5 (S)-(+)-2-methoxy-2-trifluoromethyl-2-phenylacetyl chloride 

Relevant academic research and scientific papers

Sulfobacins A and B, novel von Willebrand factor receptor antagonists. II. Structural elucidation

Sulfobacins A and B are novel von Willebrand factor (vWF) receptor antagonists produced by Chryseobacterium sp. NR 2993. The structures of sulfobacins A and B have been determined to be (2R,3R)-3-hydroxy-2-[(R)-3-hydroxy-15-methylhexadecanamido]-15- methylhexadecanesulfonic acid and (2R,3R)-3-hydroxy-15-methyl-2-[13-methyltetradecanamido]- hexadecanesulfonic acid, respectively, by various 2D NMR experiments and by methanolysis. The absolute configurations of the sulfobacins were determined by a modified MOSHER's method. The structures are related to sulfonolipids, major components of the cell envelope of gliding bacteria of the genus Cytophaga.